Soluble immune checkpoints and T-cell subsets in blood as biomarkers for resistance to immunotherapy in melanoma patients.

Oncoimmunology
Devayani MachirajuJessica C Hassel

Abstract

Different mechanisms lead to immune checkpoint inhibitor (ICI) resistance. Identifying clinically useful biomarkers might improve drug selection and patients' therapy. We analyzed the soluble immune checkpoints sPD1, sPDL1, sLAG3, and sTIM3 using ELISA and their expression on circulating T cells using FACS in pre- and on-treatment blood samples of ICI treated melanoma patients. In addition, pre-treatment melanoma metastases were stained for TIM3 and LAG3 expression by IHC. Results were correlated with treatment response and progression-free survival (PFS). Resistance to anti-PD1 treatment (n = 48) was associated with high pre-treatment serum levels of sLAG3 (DCR: p = .009; PFS: p = .018; ROC cutoff >148 pg/ml) but not sPD1, sPDL1 or sTIM3. In contrast, resistance to ipilimumab plus nivolumab (n = 42) was associated with high levels of sPD1 (DCR: p = .019, PFS: p = .046; ROC cutoff >167 pg/ml) but not sPDL1, sLAG3 or sTIM3. Both treatment regimens shared a profound increase of sPD1 serum levels with treatment (p < .0001). FACS analysis revealed reduced frequencies of CD3+ CD8+ PD1 + T cells (p = .028) in anti-PD1-resistant patients, whereas increased frequencies of CD3+ CD4+ LAG3 + T cells characterized patients resistant to ipi...Continue Reading

References

Nov 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nianyu LiDario A A Vignali
Feb 22, 2005·Immunology·Sandrine Buisson, Frédéric Triebel
Sep 21, 2005·Cellular Immunology·Christian NielsenSøren T Lillevang
Aug 19, 2006·European Journal of Immunology·Harmjan KuipersBart N Lambrecht
Jan 25, 2007·The EMBO Journal·Nianyu LiDario A A Vignali
Feb 10, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Creg J WorkmanDario A A Vignali
Mar 29, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Patrice HemonLaurence Michel
Jul 14, 2012·Journal of Translational Medicine·Wenshi WangJeffrey S Weber
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertPaolo A Ascierto
Mar 11, 2015·Nature·Christina Twyman-Saint VictorAndy J Minn
Apr 22, 2015·The New England Journal of Medicine·Caroline RobertUNKNOWN KEYNOTE-006 investigators
Jun 2, 2015·The New England Journal of Medicine·James LarkinJedd D Wolchok
Aug 16, 2016·The Journal of Clinical Investigation·Adil I DaudMichael D Rosenblum
Feb 7, 2017·Nature Communications·Shuguang TanJinghua Yan
Apr 12, 2017·Nature·Alexander C HuangE John Wherry
May 20, 2017·Cancer Immunology Research·Jun ZhouF Stephen Hodi
Jun 14, 2019·Frontiers in Medicine·Moira GravesNikola A Bowden
Aug 1, 2019·Molecular Cancer Therapeutics·Milena MusicEleftherios P Diamandis
Sep 29, 2019·The New England Journal of Medicine·James LarkinJedd D Wolchok
Oct 15, 2019·The Journal of Clinical Investigation·Alena GrosSteven A Rosenberg
Oct 23, 2019·Proceedings of the National Academy of Sciences of the United States of America·Spencer C WeiJames P Allison
Jan 9, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S UgurelV Rebmann

❮ Previous
Next ❯

Software Mentioned

FlowJo
GraphPad Prism
SPSS
Visiomorph

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.